AAAAAA

   
Results: 1-25 | 26-50 | 51-59
Results: 1-25/59
TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: DELFAVERO A ROILA F DEANGELIS V TONATO M BALLATORI E TUMOLO S MENEGHETTI L NEGRI D DELLAGASPERA S PRESOT C MURAN G LUCENTI A CICCARESE G PALLADINO MA PORROZZI S SABBATINI R DEPENNI R FEDERICO M SILINGARDI V SANSONI E MALTONI M MILANDRI C AMADORI D SABBIONI R NORTILLI R CETTO GL DOGLIOTTI L BUNIVA T GORZEGNO G LOPEZ M AMODIO A CONTI F FOGGI CM GIGLIO A DESIO L MANENTE P BERNARDO G STRADA MR VILLANI G GALLO L MERLINI L CAROTI C MAZZOTTA S FORCIGNANO R QUARTA G PACILIO C IODICE G ROSATI G MALACARNE P DONATI D MACCAFERRI R COMELLA G CASARETTI R CARRECA I RAUSA L FOSSER V SCHIAVON S GIOFFRE FM VENUTI A AMUNNI G VILLANUCCI A CONTU A PAZZOLA A PALMIOTTI G GAROFOLO G EPIFANI C GIORDANO M ANTIMI M MINELLI M DEVITA F DIGRAZIA M CRUCIANI G MONTANARI L MARCHEI P AMICI S ALESSANDRONI P CECCOLINI M CATTANEO MT ORLANDINI B AGOSTARA B MARZI M DIONISI MS DICOSTANZO F TROCCOLI L
Citation: A. Delfavero et al., TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Annals of oncology, 9(7), 1998, pp. 759-765
TREATMENT OF B-CELL LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) WITH ANTI-CD20 MONOCLONAL-ANTIBODY RITUXIMAB(R)
Authors: FEDERICO M CLO V VINCI G SACCHI S
Citation: M. Federico et al., TREATMENT OF B-CELL LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) WITH ANTI-CD20 MONOCLONAL-ANTIBODY RITUXIMAB(R), Annals of oncology, 9, 1998, pp. 27-27
EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL
Authors: FEDERICO M CLO V BURGIATELLI M CAROTENUTO M GOBBI PG VALLISA D LOMBARDO M AVANZINI P DIRENZO N DINI D BALDINI L SILINGARDI V
Citation: M. Federico et al., EFFICACY OF 2 DIFFERENT PROMACE-CYTABOM DERIVED REGIMENS IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A MULTICENTER TRIALCONDUCTED BY GISL, Haematologica, 83(9), 1998, pp. 800-811
WEEKLY ADMINISTRATION OF VINCRISTINE, CYCLOPHOSPHAMIDE, MITOXANTRONE AND BLEOMYCIN (VEMB) IN THE TREATMENT OF ELDERLY AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: MERLI F FEDERICO M AVANZINI P ILARIUCCI F STELITANO C IANNITTO E COLOMBI M VALLISA D SANTAGATI G PICCININI L
Citation: F. Merli et al., WEEKLY ADMINISTRATION OF VINCRISTINE, CYCLOPHOSPHAMIDE, MITOXANTRONE AND BLEOMYCIN (VEMB) IN THE TREATMENT OF ELDERLY AGGRESSIVE NON-HODGKINS-LYMPHOMA, Haematologica, 83(3), 1998, pp. 217-221
ELASTIC, ANELASTIC AND NONLINEAR ACOUSTIC PROPERTIES OF (ZNCL2)(X)(P2O5)(1-X) GLASSES
Authors: SIDEK HAA SENIN HB SAUNDERS GA BALL D CANKURTARAN M FEDERICO M
Citation: Haa. Sidek et al., ELASTIC, ANELASTIC AND NONLINEAR ACOUSTIC PROPERTIES OF (ZNCL2)(X)(P2O5)(1-X) GLASSES, Physics and Chemistry of Glasses, 39(1), 1998, pp. 17-22
GAG, VIF AND NEF GENES CONTRIBUTE TO THE HOMOLOGOUS VIRAL INTERFERENCE INDUCED BY A NONPRODUCER HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)VARIANT - IDENTIFICATION OF NOVEL HIV-1-INHIBITING VIRAL PROTEIN MUTANTS
Authors: DALOJA P OLIVETTA E BONA R NAPPI F PEDACCHIA D PUGLIESE K FERRARI G VERANI P FEDERICO M
Citation: P. Daloja et al., GAG, VIF AND NEF GENES CONTRIBUTE TO THE HOMOLOGOUS VIRAL INTERFERENCE INDUCED BY A NONPRODUCER HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)VARIANT - IDENTIFICATION OF NOVEL HIV-1-INHIBITING VIRAL PROTEIN MUTANTS, Journal of virology, 72(5), 1998, pp. 4308-4319
COMPOSITIONAL VARIATION OF TOURMALINE IN THE GRANITIC PEGMATITE DYKESOF THE CRUZEIRO MINE, MINAS-GERAIS, BRAZIL
Authors: FEDERICO M ANDREOZZI GB LUCCHESI S GRAZIANI G CESARMENDES J
Citation: M. Federico et al., COMPOSITIONAL VARIATION OF TOURMALINE IN THE GRANITIC PEGMATITE DYKESOF THE CRUZEIRO MINE, MINAS-GERAIS, BRAZIL, Canadian Mineralogist, 36, 1998, pp. 415-431
LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE
Authors: GOBBI PG PIERESCA C GHIRARDELLI ML DIRENZO N FEDERICO M MERIL F IANNITTO E PITINI V GRIGNANI G DONELLI A CAROTENUTO M SILINGARDI V
Citation: Pg. Gobbi et al., LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE, Blood, 91(8), 1998, pp. 2704-2712
PRODUCTIVE HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION OF PURIFIED MEGAKARYOCYTIC PROGENITORS PRECURSORS AND MATURING MEGAKARYOCYTES/
Authors: CHELUCCI C FEDERICO M GUERRIERO R MATTIA G CASELLA I PELOSI E TESTA U MARIANI G HASSAN HJ PESCHLE C
Citation: C. Chelucci et al., PRODUCTIVE HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION OF PURIFIED MEGAKARYOCYTIC PROGENITORS PRECURSORS AND MATURING MEGAKARYOCYTES/, Blood, 91(4), 1998, pp. 1225-1234
ABERRANT, NONINFECTIOUS HIV-1 PARTICLES ARE RELEASED BY CHRONICALLY INFECTED HUMAN T-CELLS TRANSDUCED WITH A RETROVIRAL VECTOR EXPRESSING AN INTERFERING HIV-1 VARIANT
Authors: BONA R DALOJA P OLIVETTA E MODESTI A MODICA A GERACI A FERRARI G VERANI P FEDERICO M
Citation: R. Bona et al., ABERRANT, NONINFECTIOUS HIV-1 PARTICLES ARE RELEASED BY CHRONICALLY INFECTED HUMAN T-CELLS TRANSDUCED WITH A RETROVIRAL VECTOR EXPRESSING AN INTERFERING HIV-1 VARIANT, Gene therapy, 4(10), 1997, pp. 1085-1092
DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS
Authors: BALLATORI E ROILA F DEANGELIS V RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M TRASSOLDATI A SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A ALLEGRINI G CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E RAMPONI S LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS, Annals of oncology, 8(6), 1997, pp. 561-567
HODGKINS-DISEASE PRESENTING BELOW THE DIAPHRAGM - THE EXPERIENCE OF THE GRUPPO-ITALIANO-STUDIO-LINFOMI (GISL)
Authors: IANNITTO E ACCURSO V FEDERICO M VALLISA D PIERESCA C GRAVINA SF DICOSTANZO F DITRAPANI R SILINGARDI V MARIANI G
Citation: E. Iannitto et al., HODGKINS-DISEASE PRESENTING BELOW THE DIAPHRAGM - THE EXPERIENCE OF THE GRUPPO-ITALIANO-STUDIO-LINFOMI (GISL), Haematologica, 82(6), 1997, pp. 676-682
SURVIVAL IN ADULT ITALIAN CANCER-PATIENTS, 1978-1989
Authors: VERDECCHIA A CAPOCACCIA R DEANGELIS R VALENTE F CHESSA E SANT M GATTA G MICHELI A BERRINO F ZANETTI R ROSSO S MAGNANI C TERRACINI B VERCELLI M CASELLA C PARODI S DELISI V SERVENTI L BARCHIELLI A BUIATTI E BALZI D CROCETTI E FALCINI F NANNI O DELEON MP RONCUCCI L FEDERICO M MANGONE L CONTI E RAMAZZOTTI V GAFA L LAROSA M
Citation: A. Verdecchia et al., SURVIVAL IN ADULT ITALIAN CANCER-PATIENTS, 1978-1989, Tumori, 83(1), 1997, pp. 39
SURVIVAL OF CHILDHOOD-CANCER PATIENTS IN ITALY, 1978-1989
Authors: MAGNANI C PASTORE G VERDECCHIA A CAPOCACCIA R DEANGELIS R VALENTE F CHESSA E SANT M GATTA G MICHELI A BERRINO F ZANETTI R ROSSO S MAGNANI C TERRACINI B MOSSO ML VERCELLI M CASELLA C PARODI S DELISI V SERVENTI L BARCHIELLI A BUIATTI E BALZI D CROCETTI E FALCINI F NANNI O DELEON MP RONCUCCI L FEDERICO M MANGONE L CONTI E RAMAZZOTTI V GAFA L LAROSA M
Citation: C. Magnani et al., SURVIVAL OF CHILDHOOD-CANCER PATIENTS IN ITALY, 1978-1989, Tumori, 83(1), 1997, pp. 426
CANCER-PATIENT SURVIVAL IN THE ELDERLY IN ITALY
Authors: VERCELLI M QUAGLIA A CASELLA C MANGONE L VERDECCHIA A CAPOCACCIA R DEANGELIS R VALENTE F CHESSA E SANT M GATTA G MICHELI A BERRINO F ZANETTI R ROSSO S TERRACINI B PARODI S DELISI V SERVENTI L BARCHIELLI A BUIATTI E BALZI D CROCETTI E FALCINI F NANNI O DELEON MP RONCUCCI L FEDERICO M CONTI E RAMAZZOTTI V GAFA L LAROSA M
Citation: M. Vercelli et al., CANCER-PATIENT SURVIVAL IN THE ELDERLY IN ITALY, Tumori, 83(1), 1997, pp. 490-496
VARIATIONS IN THE SURVIVAL OF ADULT CANCER-PATIENTS IN ITALY
Authors: GATTA G BUIATTI E CONTI E DELISI V FALCINI F FEDERICO M GAFA L DELEON MP VERCELLI M ZANETTI R
Citation: G. Gatta et al., VARIATIONS IN THE SURVIVAL OF ADULT CANCER-PATIENTS IN ITALY, Tumori, 83(1), 1997, pp. 497-504
A PILOT-STUDY ON THE USE OF THE PROMACE CYTABOM REGIMEN AS A FIRST-LINE TREATMENT OF ADVANCED FOLLICULAR NON-HODGKINS-LYMPHOMA
Authors: BALDINI L GUFFANTI A GOBBI P COLOMBI M FEDERICO M AVANZINI P CAVANNA L PIERESCA C SILINGARDI V MAIOLO AT
Citation: L. Baldini et al., A PILOT-STUDY ON THE USE OF THE PROMACE CYTABOM REGIMEN AS A FIRST-LINE TREATMENT OF ADVANCED FOLLICULAR NON-HODGKINS-LYMPHOMA, Cancer, 79(6), 1997, pp. 1234-1240
COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL)
Authors: BRUGIATELLI M FEDERICO M GOBBI P DIRENZO N VALLISA D ANGRILLI F COLOMBI M ASCARI E SILINGARDI V AMADORI S
Citation: M. Brugiatelli et al., COMPARISON OF IDARUBICIN VS EPIDOXORUBICIN-CONTAINING PROMACE-CYTABOMREGIMENS IN UNTREATED AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL), Blood, 90(10), 1997, pp. 840-840
HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-RESISTANT CD4(-7 MEGAKARYOCYTIC HUMAN CELL-LINE BECOMES HIGHLY HIV-1 AND HIV-2 SUSCEPTIBLE UPON CXCR4 TRANSFECTION - INDUCTION OF CELL-DIFFERENTIATION BY HIV-1 INFECTION() UT)
Authors: BAIOCCHI M OLIVETTA E CHELUCCI C SANTARCANGELO AC BONA R DALOJA P TESTA U KOMATSU N VERANI P FEDERICO M
Citation: M. Baiocchi et al., HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-RESISTANT CD4(-7 MEGAKARYOCYTIC HUMAN CELL-LINE BECOMES HIGHLY HIV-1 AND HIV-2 SUSCEPTIBLE UPON CXCR4 TRANSFECTION - INDUCTION OF CELL-DIFFERENTIATION BY HIV-1 INFECTION() UT), Blood, 89(8), 1997, pp. 2670-2678
STABLE TRANSFECTION OF PROVIRUS OF HUMAN-IMMUNODEFICIENCY-VIRUS INTO A MURINE PACKAGING CELL-LINE
Authors: ROZERA C BACCARINI S GENTILE M TORRISI MR PROIETTI E FEDERICO M PULCIANI S
Citation: C. Rozera et al., STABLE TRANSFECTION OF PROVIRUS OF HUMAN-IMMUNODEFICIENCY-VIRUS INTO A MURINE PACKAGING CELL-LINE, Acta virologica, 41(2), 1997, pp. 105-110
12 YEARS EXPERIENCE WITH HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HIGH-RISK HODGKINS-DISEASE PATIENTS IN FIRST REMISSION AFTER MOPP ABVD CHEMOTHERAPY/
Authors: CARELLA AM PRENCIPE E PUNGOLINO E LERMA E FRASSONI F ROSSI E GIORDANO D OCCHINI D GATTI AM BRUNI R SPRIANO M NATI S PIERLUIGI D CONGIU M VIMERCATI R RAVETTI JL FEDERICO M
Citation: Am. Carella et al., 12 YEARS EXPERIENCE WITH HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HIGH-RISK HODGKINS-DISEASE PATIENTS IN FIRST REMISSION AFTER MOPP ABVD CHEMOTHERAPY/, Leukemia & lymphoma, 21(1-2), 1996, pp. 63-70
SENSITIVE DETECTION OF CIRCULATING BREAST-CANCER CELLS BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION OF MASPIN GENE
Authors: LUPPI M MORSELLI M BANDIERI E FEDERICO M MARASCA R BAROZZI P FERRARI MG SAVARINO M FRASSOLDATI A TORELLI G
Citation: M. Luppi et al., SENSITIVE DETECTION OF CIRCULATING BREAST-CANCER CELLS BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION OF MASPIN GENE, Annals of oncology, 7(6), 1996, pp. 619-624
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION VS CONVENTIONAL THERAPY FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE RESPONDING TO FIRST-LINE THERAPY - ANALYSIS OF CLINICAL CHARACTERISTICS OF 51 PATIENTS ENROLLED IN THE HD01 PROTOCOL
Authors: FEDERICO M CLO V CARELLA AM
Citation: M. Federico et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION VS CONVENTIONAL THERAPY FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE RESPONDING TO FIRST-LINE THERAPY - ANALYSIS OF CLINICAL CHARACTERISTICS OF 51 PATIENTS ENROLLED IN THE HD01 PROTOCOL, Leukemia, 10, 1996, pp. 69-71
VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE
Authors: GOBBI PG PIERESCA C FRASSOLDATI A CAROTENUTO M DIRENZO N LASALA A BERTE R AVANZINI P FEDERICO M SILINGARDI V ASCARI E
Citation: Pg. Gobbi et al., VINBLASTINE, BLEOMYCIN, AND METHOTREXATE CHEMOTHERAPY PLUS EXTENDED-FIELD RADIOTHERAPY IN EARLY, FAVORABLY PRESENTING, CLINICALLY STAGED HODGKINS PATIENTS - THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI EXPERIENCE, Journal of clinical oncology, 14(2), 1996, pp. 527-533
CCNU, VINBLASTINE, PROCARBAZINE AND PREDNISONE (CVPP) WITH EXTENDED-FIELD RADIOTHERAPY IN THE TREATMENT OF EARLY UNFAVORABLE HODGKINS-DISEASE - A PROSPECTIVE-STUDY ON BEHALF OF THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI (GISL)
Authors: GOBBI PG PIERESCA C CAVANNA L CORBELLA F VALLISA D FEDERICO M FORMISANO R CAROTENUTO M MERLI F CALLEA V ANGRILLI F SILINGARDI V
Citation: Pg. Gobbi et al., CCNU, VINBLASTINE, PROCARBAZINE AND PREDNISONE (CVPP) WITH EXTENDED-FIELD RADIOTHERAPY IN THE TREATMENT OF EARLY UNFAVORABLE HODGKINS-DISEASE - A PROSPECTIVE-STUDY ON BEHALF OF THE GRUPPO-ITALIANO-PER-LO-STUDIO-DEI-LINFOMI (GISL), Haematologica, 81(6), 1996, pp. 503-512
Risultati: 1-25 | 26-50 | 51-59